Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Cushman-and-Wakefield stock
Learn how to easily invest in Cushman-and-Wakefield stock.
Cushman & Wakefield plc is a real estate services business based in the US. Cushman-and-Wakefield shares (CWK) are listed on the NYSE and all prices are listed in US Dollars. Cushman-and-Wakefield employs 50,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Cushman-and-Wakefield
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CWK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cushman-and-Wakefield stock price (NYSE: CWK)Use our graph to track the performance of CWK stocks over time.
Cushman-and-Wakefield shares at a glance
|Latest market close||$21.80|
|52-week range||$13.89 - $22.77|
|50-day moving average||$19.92|
|200-day moving average||$18.41|
|Wall St. target price||$27.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.34|
Buy Cushman-and-Wakefield shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cushman-and-Wakefield stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cushman-and-Wakefield price performance over time
|1 week (2022-01-10)||1.87%|
|1 month (2021-12-17)||7.13%|
|3 months (2021-10-15)||17.39%|
|6 months (2021-07-16)||28.99%|
|1 year (2021-01-15)||53.74%|
|2 years (2020-01-17)||10.77%|
|3 years (2019-01-17)||29.30%|
|5 years (2017-01-13)||N/A|
Is Cushman-and-Wakefield stock undervalued or overvalued?
Valuing Cushman-and-Wakefield stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cushman-and-Wakefield's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cushman-and-Wakefield's P/E ratio
Cushman-and-Wakefield's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 63x. In other words, Cushman-and-Wakefield shares trade at around 63x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Cushman-and-Wakefield's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $575.7 million.
The EBITDA is a measure of a Cushman-and-Wakefield's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$8.8 billion|
|Operating margin TTM||4.5%|
|Gross profit TTM||$1.4 billion|
|Return on assets TTM||3.38%|
|Return on equity TTM||6.74%|
|Market capitalisation||$4.9 billion|
TTM: trailing 12 months
Cushman-and-Wakefield share dividends
We're not expecting Cushman-and-Wakefield to pay a dividend over the next 12 months.
Cushman-and-Wakefield share price volatility
Over the last 12 months, Cushman-and-Wakefield's shares have ranged in value from as little as $13.89 up to $22.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cushman-and-Wakefield's is 1.4408. This would suggest that Cushman-and-Wakefield's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. The company operates through Americas; Europe, Middle East, and Africa; and Asia Pacific segments. It offers integrated facilities management, project and development, portfolio administration, transaction management, and strategic consulting services; property management services, including client accounting, engineering and operations, lease compliance administration, project and development, and sustainability services; and self-performed facilities services, which include janitorial, maintenance, critical environment management, landscaping, and office services. The company also provides owner representation and tenant representation leasing services; capital market services, such as investment sales and equity, and debt and structured financing for real estate purchase and sales transactions; and appraisal management, investment management, valuation advisory, portfolio advisory, diligence advisory, dispute analysis and litigation support, financial reporting, and property and/or portfolio valuation services on real estate debt and equity decisions. Cushman & Wakefield has strategic partnerships with Vanke Service and WeWork Inc. It serves real estate owners and occupiers, such as tenants, investors, and multi-national corporations. Cushman & Wakefield plc was founded in 1784 and is based in London, the United Kingdom.
Cushman-and-Wakefield in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Cushman & Wakefield Releases Data Center Global Market Comparison Report
Alternative Asset Management Firm TPG Launches IPO
Frequently asked questionsWhat percentage of Cushman-and-Wakefield is owned by insiders or institutions?
Currently 19.998% of Cushman-and-Wakefield shares are held by insiders and 79.992% by institutions. How many people work for Cushman-and-Wakefield?
Latest data suggests 50,000 work at Cushman-and-Wakefield. When does the fiscal year end for Cushman-and-Wakefield?
Cushman-and-Wakefield's fiscal year ends in December. Where is Cushman-and-Wakefield based?
Cushman-and-Wakefield's address is: 125 Old Broad Street, London, United Kingdom, EC2N 1AR What is Cushman-and-Wakefield's ISIN number?
Cushman-and-Wakefield's international securities identification number is: GB00BFZ4N465 What is Cushman-and-Wakefield's CUSIP number?
Cushman-and-Wakefield's Committee on Uniform Securities Identification Procedures number is: G2717B108
More guides on Finder
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
Ask an Expert